Methamphetamine Sales Training from DEA/DOJ?
Registered with the DEA after completing the ephedrine, pseudoephedrine, and phenylpropanolamine sales training from the DOJ and DEA for only $21. Seems way to easy to be able to legally possess and sell Scheduled listed drugs made from these list 1 drugs, like Methamphetamines which is listed on list 2.
Not sure about the ethics on selling Methamphetamines, I guess if you make sure it only goes to the right people. I would love to hear others input on it. Know anyone who has seen this before? I mean other than places like pharmacies which this doesn’t require being. The training you take before you self certify that you read and are/will be in compliance with it states you can’t sell scheduled listed narcotics made from the 3 drugs listed on the self-certification until you’ve completed the training which comprises of reading at least 1 of the 3 pdf’s listed below .
I assume the spirit of the laws created were to stop street dealers and bad people from ruining peoples lives with Methamphetamines but the wording seems to just say once you complete this training it is no longer illegal to posses and sell any scheduled listed drug products made from these list 1 drugs, Methamphetamines are specifically listed on list 2. There is also a 3600 dollar manufacturing
In my opinion it’d be good for people with ADD/ADHD and a few other conditions but for most it would likely have a negative impact on their life.
Here is an excerpt from https://www.deadiversion.usdoj.gov/fed_regs/rules/2008/fr0118.htm
DEA’s Legal Authority
DEA implements the Comprehensive Drug Abuse Prevention and Control Act of 1970, often referred to as the Controlled Substances Act (CSA) and the Controlled Substances Import and Export Act (21 U.S.C. 801- 971), as amended. DEA publishes the implementing regulations for these statutes in Title 21 of the Code of Federal Regulations (CFR), Parts 1300 to 1399. These regulations are designed to ensure that there is a sufficient supply of controlled substances for legitimate medical, scientific, and industrial purposes and to deter the diversion of controlled substances to illegal purposes. The CSA mandates that DEA establish a closed system of control for manufacturing, distributing, and dispensing controlled substances.
“Any person who manufactures, distributes, dispenses, imports, exports, or conducts research or chemical analysis with controlled substances must register with DEA (unless exempt) and comply with the applicable requirements for the activity.”
The CSA as amended also requires DEA to regulate the manufacture, distribution, import, and export of chemicals that may be used to manufacture controlled substances illegally. Listed chemicals that are classified as List I chemicals are important to the manufacture of controlled substances. Those classified as List II chemicals may be used to manufacture controlled substances.
On March 9, 2006, the President signed the Combat Methamphetamine Epidemic Act of 2005 (CMEA), which is Title VII of the USA PATRIOT Improvement and Reauthorization Act of 2005 (Pub. L. 109-177). Much of CMEA is self-implementing; the provisions related to importation of ephedrine, pseudoephedrine, and phenylpropanolamine, import quotas, manufacturing quotas, and procurement quotas became effective on March 9, 2006.
CMEA Requirements and Impact on Registration
CMEA amended the CSA to include ephedrine, pseudoephedrine, and phenylpropanolamine in 21 U.S.C. 826 (Production quotas for controlled substances) and section 952(a) (Importation of controlled substances). Congress essentially imposed the same requirements for importation of ephedrine, pseudoephedrine, and phenylpropanolamine as are imposed on narcotic raw materials–crude opium, poppy straw, concentrate of poppy straw, and coca leaves.
That is, imports of ephedrine, pseudoephedrine, and phenylpropanolamine are prohibited except for such amounts as the Attorney General (DEA by delegation) finds to be necessary to provide for medical, scientific, or other legitimate purposes. Congress also imposed the same requirements on the manufacture of ephedrine, pseudoephedrine, and phenylpropanolamine as are established for Schedule I and II controlled substances. That is, Congress mandated the establishment of a total need for ephedrine, pseudoephedrine, and phenylpropanolamine to be manufactured each calendar year to provide for the estimated medical, scientific, research, and industrial needs of the United States, for lawful export requirements, and for the establishment and maintenance of reserve stocks. These requirements apply equally to products containing these three List I chemicals as they do to the List I chemicals themselves.
Controlled substances are subject to a closed system of controls that ensures that no person may manufacture, distribute, import, export, or dispense unless that person is a DEA registrant, or exempted from the requirement of registration. Production of Schedule I and II controlled substances is limited to the quantity that DEA has determined is required to meet the legitimate medical, scientific, research, and industrial needs of the United States; for
Some training that has been updated updated January 2017, https://www.deadiversion.usdoj.gov/mtgs/pharm_awareness/conf_2017/jan_2017/elkholy.pdf
I added a copy to my server below as well in case the USDOJ link is moved or removed.
Training by the DEA Required to Sell Drug Products Containing Ephedrine, Pseudoephedrine, and Phenylpropanolamine is downloadable below. A link to where you can pay your Self Certification Fee after completing the training (read the pdfs) is available at https://www.deadiversion.usdoj.gov/meth/index.html#self_cert